▶ 調査レポート

予防用ヒトワクチンの中国市場2017

• 英文タイトル:China Prophylactic Human Vaccine Market Research Report 2017

QYResearchが調査・発行した産業分析レポートです。予防用ヒトワクチンの中国市場2017 / China Prophylactic Human Vaccine Market Research Report 2017 / A042124815資料のイメージです。• レポートコード:A042124815
• 出版社/出版日:QYResearch / 2017年3月16日
• レポート形態:英文、PDF、110ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医療・製薬・バイオ
• 販売価格(消費税別)
  Single User¥345,600 (USD3,200)▷ お問い合わせ
  Enterprise¥691,200 (USD6,400)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、予防用ヒトワクチンの中国市場について調査・分析し、予防用ヒトワクチンの中国市場概観、予防用ヒトワクチンの種類別市場分析、用途別市場分析、予防用ヒトワクチンの中国市場規模予測、関連企業分析、関連企業情報、価格情報、販売動向、中国市場動向、貿易動向、市場環境分析情報などを含め、以下の構成でお届けいたします。

・予防用ヒトワクチンの中国市場概観
・予防用ヒトワクチンの種類別市場規模
・予防用ヒトワクチンの用途別市場規模
・予防用ヒトワクチンの中国市場規模
・予防用ヒトワクチンの中国市場予測
・予防用ヒトワクチンの製造メーカー分析
・予防用ヒトワクチンのメーカー別生産量
・予防用ヒトワクチンのメーカー別市場シェア
・予防用ヒトワクチンの価格動向・価格分析
・予防用ヒトワクチンの販売(売上高)動向
・予防用ヒトワクチンの貿易(輸出・輸入)動向
・予防用ヒトワクチンの産業チェーン分析
・予防用ヒトワクチンのマーケティング戦略分析
・予防用ヒトワクチンの販売業者(代理店)リスト
・予防用ヒトワクチンの市場環境分析
...

Notes:Sales, means the sales volume of Prophylactic Human Vaccine
Revenue, means the sales value of Prophylactic Human Vaccine

This report studies Prophylactic Human Vaccine in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering
Bavarian Nordic A/S
BiondVax Pharmaceuticals Ltd
Bharat Biotech International Limited
GlaxoSmithKline
Hualan Biological Engineering
Janssen Pharmaceuticals
MedImmune
Merck
Pfizer
Sanofi Pasteur SA
Serum Institute of India Pvt
Shanghai BravoBio

Market Segment by Regions (provinces), covering
South China
East China
Southwest China
Northeast China
North China
Central China
Northwest China
Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Split by Application, this report focuses on consumption, market share and growth rate of Prophylactic Human Vaccine in each application, can be divided into
Application 1
Application 2

レポート目次

Table of Contents

China Prophylactic Human Vaccine Market Research Report 2017
1 Prophylactic Human Vaccine Market Overview
1.1 Product Overview and Scope of Prophylactic Human Vaccine
1.2 Prophylactic Human Vaccine Segment by Type
1.2.1 China Production Market Share of Prophylactic Human Vaccine Type in 2015
1.2.2 Type I
1.2.3 Type II
1.3 Applications of Prophylactic Human Vaccine
1.3.1 Prophylactic Human Vaccine Consumption Market Share by Application in 2015
1.3.2 Application 1
1.3.3 Application 2
1.4 China Market Size (Value) of Prophylactic Human Vaccine (2012-2022)
1.5 China Prophylactic Human Vaccine Status and Outlook
1.6 Government Policies

2 China Prophylactic Human Vaccine Market Competition by Manufacturers
2.1 China Prophylactic Human Vaccine Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China Prophylactic Human Vaccine Revenue and Share by Manufacturers (2015 and 2016)
2.3 China Prophylactic Human Vaccine Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Prophylactic Human Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Prophylactic Human Vaccine Market Competitive Situation and Trends
2.5.1 Prophylactic Human Vaccine Market Concentration Rate
2.5.2 Prophylactic Human Vaccine Market Share of Top 3 and Top 5 Manufacturers

3 China Prophylactic Human Vaccine Manufacturers Profiles/Analysis
3.1 Bavarian Nordic A/S
3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.1.2 Prophylactic Human Vaccine Product Type, Application and Specification
3.1.2.1 Product A
3.1.2.2 Product B
3.1.3 Bavarian Nordic A/S Prophylactic Human Vaccine Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.1.4 Main Business/Business Overview
3.2 BiondVax Pharmaceuticals Ltd
3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.2.2 Prophylactic Human Vaccine Product Type, Application and Specification
3.2.2.1 Product A
3.2.2.2 Product B
3.2.3 BiondVax Pharmaceuticals Ltd Prophylactic Human Vaccine Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.2.4 Main Business/Business Overview
3.3 Bharat Biotech International Limited
3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.3.2 Prophylactic Human Vaccine Product Type, Application and Specification
3.3.2.1 Product A
3.3.2.2 Product B
3.3.3 Bharat Biotech International Limited Prophylactic Human Vaccine Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.3.4 Main Business/Business Overview
3.4 GlaxoSmithKline
3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.4.2 Prophylactic Human Vaccine Product Type, Application and Specification
3.4.2.1 Product A
3.4.2.2 Product B
3.4.3 GlaxoSmithKline Prophylactic Human Vaccine Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.4.4 Main Business/Business Overview
3.5 Hualan Biological Engineering
3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.5.2 Prophylactic Human Vaccine Product Type, Application and Specification
3.5.2.1 Product A
3.5.2.2 Product B
3.5.3 Hualan Biological Engineering Prophylactic Human Vaccine Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.5.4 Main Business/Business Overview
3.6 Janssen Pharmaceuticals
3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.6.2 Prophylactic Human Vaccine Product Type, Application and Specification
3.6.2.1 Product A
3.6.2.2 Product B
3.6.3 Janssen Pharmaceuticals Prophylactic Human Vaccine Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.6.4 Main Business/Business Overview
3.7 MedImmune
3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.7.2 Prophylactic Human Vaccine Product Type, Application and Specification
3.7.2.1 Product A
3.7.2.2 Product B
3.7.3 MedImmune Prophylactic Human Vaccine Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.7.4 Main Business/Business Overview
3.8 Merck
3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.8.2 Prophylactic Human Vaccine Product Type, Application and Specification
3.8.2.1 Product A
3.8.2.2 Product B
3.8.3 Merck Prophylactic Human Vaccine Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.8.4 Main Business/Business Overview
3.9 Pfizer
3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.9.2 Prophylactic Human Vaccine Product Type, Application and Specification
3.9.2.1 Product A
3.9.2.2 Product B
3.9.3 Pfizer Prophylactic Human Vaccine Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.9.4 Main Business/Business Overview
3.10 Sanofi Pasteur SA
3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.10.2 Prophylactic Human Vaccine Product Type, Application and Specification
3.10.2.1 Product A
3.10.2.2 Product B
3.10.3 Sanofi Pasteur SA Prophylactic Human Vaccine Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.10.4 Main Business/Business Overview
3.11 Serum Institute of India Pvt
3.12 Shanghai BravoBio

4 China Prophylactic Human Vaccine Capacity, Production, Revenue, Consumption, Export and Import (2012-2017)
4.1 China Prophylactic Human Vaccine Capacity, Production and Growth (2012-2017)
4.2 China Prophylactic Human Vaccine Revenue and Growth (2012-2017)
4.3 China Prophylactic Human Vaccine Production, Consumption, Export and Import (2012-2017)

5 China Prophylactic Human Vaccine Production, Revenue (Value), Price Trend by Type
5.1 China Prophylactic Human Vaccine Production and Market Share by Type (2012-2017)
5.2 China Prophylactic Human Vaccine Revenue and Market Share by Type (2012-2017)
5.3 China Prophylactic Human Vaccine Price by Type (2012-2017)
5.4 China Prophylactic Human Vaccine Production Growth by Type (2012-2017)

6 China Prophylactic Human Vaccine Market Analysis by Application
6.1 China Prophylactic Human Vaccine Consumption and Market Share by Application (2012-2017)
6.2 China Prophylactic Human Vaccine Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Application
6.3.2 Emerging Markets/Countries

7 ChinaProphylactic Human Vaccine Market Analysis by Regions (Provinces)
7.1 China Prophylactic Human Vaccine Production, Production Value and Price by Regions (Provinces)(2012-2017)
7.1.1 China Prophylactic Human Vaccine Production and Market Share by Regions (Provinces)(2012-2017)
7.1.2 China Prophylactic Human Vaccine Production Value and Market Share by Regions (Provinces)(2012-2017)
7.1.3 China Prophylactic Human Vaccine Sales Price by Regions (Provinces)(2012-2017)
7.2 China Prophylactic Human Vaccine Consumption by Regions (Provinces)(2012-2017)
7.3 China Prophylactic Human Vaccine Production, Consumption, Export and Import (2012-2017)

8 Prophylactic Human Vaccine Manufacturing Cost Analysis
8.1 Prophylactic Human Vaccine Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Prophylactic Human Vaccine

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Prophylactic Human Vaccine Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Prophylactic Human Vaccine Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 China Prophylactic Human Vaccine Market Forecast (2017-2022)
12.1 China Prophylactic Human Vaccine Capacity, Production, Revenue Forecast (2017-2022)
12.2 China Prophylactic Human Vaccine Production, Import, Export and Consumption Forecast (2017-2022)
12.3 China Prophylactic Human Vaccine Production Forecast by Type (2017-2022)
12.4 China Prophylactic Human Vaccine Consumption Forecast by Application (2017-2022)
12.5 China Prophylactic Human Vaccine Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.5.1 China Prophylactic Human Vaccine Production Forecast by Regions (Provinces)(2017-2022)
12.5.2 China Prophylactic Human Vaccine Consumption Forecast by Regions (Provinces)(2017-2022)
12.5.3 China Prophylactic Human Vaccine Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.6 Prophylactic Human Vaccine Price Forecast (2017-2022)

13 Research Findings and Conclusion

14 Appendix
Methodology
Analyst Introduction
Data Source

List of Tables and Figures

Figure Picture of Prophylactic Human Vaccine
Figure China Production Market Share of Prophylactic Human Vaccine by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Table Prophylactic Human Vaccine Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure China Prophylactic Human Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Table China Prophylactic Human Vaccine Capacity of Key Manufacturers (2015 and 2016)
Table China Prophylactic Human Vaccine Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Prophylactic Human Vaccine Capacity of Key Manufacturers in 2015
Figure China Prophylactic Human Vaccine Capacity of Key Manufacturers in 2016
Table China Prophylactic Human Vaccine Production of Key Manufacturers (2015 and 2016)
Table China Prophylactic Human Vaccine Production Share by Manufacturers (2015 and 2016)
Figure 2015 Prophylactic Human Vaccine Production Share by Manufacturers
Figure 2016 Prophylactic Human Vaccine Production Share by Manufacturers
Table China Prophylactic Human Vaccine Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Prophylactic Human Vaccine Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Prophylactic Human Vaccine Revenue Share by Manufacturers
Table 2016 China Prophylactic Human Vaccine Revenue Share by Manufacturers
Table China Market Prophylactic Human Vaccine Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Prophylactic Human Vaccine Average Price of Key Manufacturers in 2015
Table Manufacturers Prophylactic Human Vaccine Manufacturing Base Distribution and Sales Area
Table Manufacturers Prophylactic Human Vaccine Product Type
Figure Prophylactic Human Vaccine Market Share of Top 3 Manufacturers
Figure Prophylactic Human Vaccine Market Share of Top 5 Manufacturers
Table Bavarian Nordic A/S Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bavarian Nordic A/S Prophylactic Human Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Bavarian Nordic A/S Prophylactic Human Vaccine Market Share (2012-2017)
Table BiondVax Pharmaceuticals Ltd Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table BiondVax Pharmaceuticals Ltd Prophylactic Human Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure BiondVax Pharmaceuticals Ltd Prophylactic Human Vaccine Market Share (2012-2017)
Table Bharat Biotech International Limited Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bharat Biotech International Limited Prophylactic Human Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Bharat Biotech International Limited Prophylactic Human Vaccine Market Share (2012-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Prophylactic Human Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure GlaxoSmithKline Prophylactic Human Vaccine Market Share (2012-2017)
Table Hualan Biological Engineering Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hualan Biological Engineering Prophylactic Human Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Hualan Biological Engineering Prophylactic Human Vaccine Market Share (2012-2017)
Table Janssen Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Janssen Pharmaceuticals Prophylactic Human Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Janssen Pharmaceuticals Prophylactic Human Vaccine Market Share (2012-2017)
Table MedImmune Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table MedImmune Prophylactic Human Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure MedImmune Prophylactic Human Vaccine Market Share (2012-2017)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Prophylactic Human Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Merck Prophylactic Human Vaccine Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Prophylactic Human Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Prophylactic Human Vaccine Market Share (2012-2017)
Table Sanofi Pasteur SA Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Pasteur SA Prophylactic Human Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Sanofi Pasteur SA Prophylactic Human Vaccine Market Share (2012-2017)
Table Serum Institute of India Pvt Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Shanghai BravoBio Basic Information, Manufacturing Base, Sales Area and Its Competitors
Figure China Prophylactic Human Vaccine Capacity, Production and Growth (2012-2017)
Figure China Prophylactic Human Vaccine Revenue (Million USD) and Growth (2012-2017)
Table China Prophylactic Human Vaccine Production, Consumption, Export and Import (2012-2017)
Table China Prophylactic Human Vaccine Production by Type (2012-2017)
Table China Prophylactic Human Vaccine Production Share by Type (2012-2017)
Figure Production Market Share of Prophylactic Human Vaccine by Type (2012-2017)
Figure 2015 Production Market Share of Prophylactic Human Vaccine by Type
Table China Prophylactic Human Vaccine Revenue by Type (2012-2017)
Table China Prophylactic Human Vaccine Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Prophylactic Human Vaccine by Type (2012-2017)
Figure 2015 Revenue Market Share of Prophylactic Human Vaccine by Type
Table China Prophylactic Human Vaccine Price by Type (2012-2017)
Figure China Prophylactic Human Vaccine Production Growth by Type (2012-2017)
Table China Prophylactic Human Vaccine Consumption by Application (2012-2017)
Table China Prophylactic Human Vaccine Consumption Market Share by Application (2012-2017)
Figure China Prophylactic Human Vaccine Consumption Market Share by Application in 2015
Table China Prophylactic Human Vaccine Consumption Growth Rate by Application (2012-2017)
Figure China Prophylactic Human Vaccine Consumption Growth Rate by Application (2012-2017)
Table China Prophylactic Human Vaccine Production by Regions (Provinces)(2012-2017)
Table China Prophylactic Human Vaccine Production Market Share by Regions (Provinces)(2012-2017)
Table China Prophylactic Human Vaccine Production Value by Regions (Provinces)(2012-2017)
Table China Prophylactic Human Vaccine Production Value Market Share by Regions (Provinces)(2012-2017)
Table China Prophylactic Human Vaccine Sales Price by Regions (Provinces)(2012-2017)
Table China Prophylactic Human Vaccine Consumption by Regions (Provinces)(2012-2017)
Table China Prophylactic Human Vaccine Consumption Market Share by Regions (Provinces)(2012-2017)
Table China Prophylactic Human Vaccine Production, Consumption, Export and Import (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Prophylactic Human Vaccine
Figure Manufacturing Process Analysis of Prophylactic Human Vaccine
Figure Prophylactic Human Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Prophylactic Human Vaccine Major Manufacturers in 2015
Table Major Buyers of Prophylactic Human Vaccine
Table Distributors/Traders List
Figure China Prophylactic Human Vaccine Capacity, Production and Growth Rate Forecast (2017-2022)
Figure China Prophylactic Human Vaccine Revenue and Growth Rate Forecast (2017-2022)
Table China Prophylactic Human Vaccine Production, Import, Export and Consumption Forecast (2017-2022)
Table China Prophylactic Human Vaccine Production Forecast by Type (2017-2022)
Table China Prophylactic Human Vaccine Consumption Forecast by Application (2017-2022)
Table China Prophylactic Human Vaccine Production Forecast by Regions (Provinces)(2017-2022)
Table China Prophylactic Human Vaccine Consumption Forecast by Regions (Provinces)(2017-2022)
Table China Prophylactic Human Vaccine Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)